Lung Cancer Trial, Recruiting NCT07528066 Sponsor: Shanghai Chest Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07528066
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • Your lung cancer diagnosis has been confirmed through a tissue sample (biopsy), and it is a type called non-small cell lung cancer (NSCLC)
  • Your cancer is at a specific stage (stage IIB or III, with no spread to distant parts of the body) and a specialist medical team has agreed it can be, or potentially can be, removed by surgery
  • Your treatment plan includes a combination of chemotherapy and immunotherapy before surgery, with the goal of curing the cancer (some additional radiation before surgery is also allowed)
  • You have already received at least one round of this chemotherapy and immunotherapy combination
  • You had a chest scan (CT scan, and possibly a PET scan) within 6 weeks before starting your pre-surgery treatment
  • You had a follow-up chest scan (CT and/or PET) between 2 and 6 weeks after your last dose of pre-surgery treatment
  • Your surgery is planned to take place between 2 and 10 weeks after your last treatment dose, with the goal of curing the cancer
  • Your surgeon plans to check and remove nearby lymph nodes during the operation
  • You are generally well enough to carry out light activity or self-care (confirm with trial site)
  • You are able to attend follow-up appointments for at least 90 days after surgery
  • You are able to understand and agree to take part in the trial by signing a consent form

Who may not be able to join:

  • Your cancer has spread to other parts of the body (called metastatic or stage M1 disease), either at diagnosis or discovered later
  • Your pre-surgery treatment does not include an immunotherapy drug (unless you are part of a specific comparison group in the trial — confirm with trial site)
  • You have already had chemotherapy, other systemic treatment, or radiation to the chest for this lung cancer before starting the current pre-surgery treatment
  • Your planned pre-surgery treatment is chemotherapy combined with radiation only, without immunotherapy
  • A decision was made against having surgery before your pre-surgery treatment even began
  • You have an active autoimmune disease (where the immune system attacks the body) that has needed medication to suppress the immune system within the last 2 years, have previously had an organ transplant, or have a history of moderate or severe lung inflammation (confirm with trial site)
  • You have an infection that is not under control, are pregnant or breastfeeding, or have any other condition that a specialist medical team feels would prevent you from safely having surgery with the goal of a cure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Chest Hospital
Registry
ClinicalTrials.gov
Start date
2 March 2026
Est. completion
30 March 2027

Where this trial is recruiting

🇨🇳 China 🇫🇷 France 🇮🇹 Italy

Primary endpoints

Complete resection (R0 resection)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov